Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A post-hoc pooled analysis to evaluate efficacy and safety of insulin glargine 300 U/mL in insulin-naïve people with type 2 diabetes with/without prior use of glucagon-like peptide-1 receptor agonist therapy.
Cheng AYY, Mauricio D, Ritzel R, Al-Sofiani ME, Bailey T, Aileen Mabunay M, Bonnemaire M, Melas-Melt L, Mimouni S, Davies M. Cheng AYY, et al. Diabetes Res Clin Pract. 2024 Nov;217:111871. doi: 10.1016/j.diabres.2024.111871. Epub 2024 Sep 27. Diabetes Res Clin Pract. 2024. PMID: 39343145 Free article.
Shaping the future of heart health.
Cheng AYY, Zhang S, von Haehling S, Desai M. Cheng AYY, et al. Med. 2024 Sep 13;5(9):1035-1037. doi: 10.1016/j.medj.2024.08.002. Med. 2024. PMID: 39276765
Time-in-range derived from self-measured blood glucose in people with type 2 diabetes advancing to iGlarLixi: A participant-level pooled analysis of three phase 3 LixiLan randomized controlled trials.
Haluzík M, Al-Sofiani ME, Cheng AYY, Lauand F, Melas-Melt L, Rosenstock J. Haluzík M, et al. Among authors: cheng ayy. Diabetes Obes Metab. 2024 Nov;26(11):5046-5055. doi: 10.1111/dom.15811. Epub 2024 Sep 8. Diabetes Obes Metab. 2024. PMID: 39245809 Clinical Trial.
Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis.
Usman MS, Bhatt DL, Hameed I, Anker SD, Cheng AYY, Hernandez AF, Jones WS, Khan MS, Petrie MC, Udell JA, Friede T, Butler J. Usman MS, et al. Among authors: cheng ayy. Lancet Diabetes Endocrinol. 2024 Jul;12(7):447-461. doi: 10.1016/S2213-8587(24)00102-5. Epub 2024 May 17. Lancet Diabetes Endocrinol. 2024. PMID: 38768620
Reflecting on a Year at the Helm of Diabetes Care.
Kahn SE, Anderson CAM, Buse JB, Selvin E, Angell SY, Aroda VR, Cheng AYY, Danne T, Echouffo-Tcheugui JB, Fitzpatrick SL, Gadgil MD, Gastaldelli A, Gloyn AL, Green JB, Jastreboff AM, Kanaya AM, Kandula NR, Kovesdy CP, Laiteerapong N, Nadeau KJ, Pettus J, Pop-Busui R, Posey JE, Powe CE, Rebholz CM, Rickels MR, Sattar N, Shaw JE, Sims EK, Utzschneider KM, Vella A, Zhang C. Kahn SE, et al. Among authors: cheng ayy. Diabetes Care. 2024 Jan 1;47(1):4-6. doi: 10.2337/dci23-0089. Diabetes Care. 2024. PMID: 38117988 No abstract available.
62 results